Physiomics Plc (AIM:PYC)

Market Cap	1.18M
Revenue (ttm)	834.16K
Net Income (ttm)	-415.25K
Shares Out	303.21M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,322,989
Average Volume	3,568,090
Open	0.3950
Previous Close	0.3900
Day's Range	0.3830 - 0.4222
52-Week Range	0.3800 - 1.4000
Beta	0.86
RSI	36.16
Earnings Date	Dec 4, 2025

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 10
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: PYC

Financial Performance

In 2025, Physiomics's revenue was 834,156, an increase of 46.20% compared to the previous year's 570,561. Losses were -415,254, -31.85% less than in 2024.